Passage Bio Inc. – Filings and Transcripts

NASDAQ: PASG
Share price (8/7/26): $4.40
Market cap (8/7/26): $14.1 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Business combination disclosure

Details of business combination or exchange offer

Business combination disclosure

Business combination disclosure

Registration of securities for employees

Ownership Filter

Lynx1 Capital Management LP

Nichols Weston, Lynx1 Capital Management LP

Baselake Partners, LP

News Filter

Passage Bio and Remix Therapeutics Announce Merger Agreement

Termination of Material Definitive Agreement

Shareholder Vote Results

Cost of Exit or Disposal Activities

Reports Updated Interim Data From Uplift-D Trial and Provides Regulatory and Corporate Updates

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission